Krebs Biochemicals and Industries quarterly results and financials

Krebs Biochemicals and Industries (KREBSBIO)₹59.62+3.69%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Krebs Biochemicals and Industries reported sales of ₹6.97 Cr, up 27.4% from Jun 2025, and net profit of −₹2.47 Cr. For the year to Mar 2026, sales were ₹23.97 Cr and net profit −₹17.02 Cr.

Sales (Jun 2026): ₹6.97 Cr
Net profit (Jun 2026): −₹2.47 Cr
Sales (FY Mar 2026): ₹23.97 Cr
Net profit (FY Mar 2026): −₹17.02 Cr
EPS (Jun 2026): ₹−1.16
Borrowings (Mar 2026): ₹225 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Krebs Biochemicals and Industries quarterly results

₹ crore unless stated; each column is a quarter.

Krebs Biochemicals and Industries Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	14.87	12.95	11.95	12.87	12.84	11.45	6.08	5.47	4.16	7.26	6.80	6.97
Expenses	15.82	15.11	15.13	15.13	15.61	16.21	11.54	7.59	6.99	6.98	7.69	6.18
Operating Profit	−0.89	−2.08	−3.11	−2.18	−2.71	−4.70	−5.39	−2.08	−2.79	0.29	−0.85	0.81
OPM %	−6.0%	−16.1%	−26.1%	−17.0%	−21.1%	−41.1%	−88.7%	−38.2%	−67.1%	4.1%	−12.6%	11.7%
Other Income	0.18	0.04	0.22	0.04	0.10	0.26	0.35	0.02	0.02	0.00	2.01	0.17
Interest	1.14	1.18	1.26	1.33	1.41	1.57	1.60	1.64	1.72	1.78	1.90	1.89
Depreciation	1.72	1.74	1.68	1.70	1.72	1.73	1.58	1.61	1.63	1.64	1.58	1.60
Profit before tax	−3.56	−4.97	−5.84	−5.18	−5.75	−7.73	−8.24	−5.32	−6.15	−3.13	−2.33	−2.48
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	−3.58	−4.99	−5.86	−5.18	−5.77	−7.75	−8.28	−5.33	−6.15	−3.14	−2.35	−2.47
EPS (Rs)	−1.67	−2.32	−2.72	−2.41	−2.68	−3.60	−3.85	−2.48	−2.86	−1.46	−1.10	−1.16

Krebs Biochemicals and Industries profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Krebs Biochemicals and Industries Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.99	2.99	33.93	47.87	32.93	53.85	59.84	51.90	49.90	42.88	23.97	25.19
Expenses	14.03	11.02	41.13	58.12	52.16	71.15	94.23	68.13	59.16	58.15	29.08	27.84
Operating Profit	−11.97	−7.98	−7.97	−9.97	−18.93	−17.94	−33.93	−15.96	−8.97	−14.95	−4.99	−2.54
OPM %	−1,088.0%	−248.0%	−22.0%	−20.0%	−56.0%	−33.0%	−57.0%	−30.0%	−17.0%	−35.0%	−23.0%	−10.1%
Other Income	1.01	0.00	−1.01	0.00	0.00	1.01	1.01	1.01	0.00	1.01	2.01	2.20
Interest	0.99	3.01	4.99	5.99	5.99	6.01	4.99	2.99	4.99	5.99	6.99	7.29
Depreciation	4.02	4.01	4.01	4.01	5.02	5.01	6.02	7.02	7.02	7.02	6.02	6.45
Profit before tax	−15.99	−15.99	−18.01	−19.98	−28.98	−27.99	−44.99	−24.98	−19.99	−26.97	−16.99	−14.09
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—
Exceptional items	0.27	−0.39	−1.20	0.10	0.00	0.00	0.00	0.00	0.00	0.11	0.00	—
Net Profit	−15.99	−16.02	−18.02	−20.01	−29.01	−28.03	−45.06	−24.99	−20.02	−27.01	−17.02	−14.11
EPS (Rs)	−10.34	−9.68	−10.74	−12.04	−16.06	−14.47	−20.69	−11.47	−9.16	−12.52	−7.86	−6.58
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Krebs Biochemicals and Industries balance sheet

₹ crore, at each year end.

Krebs Biochemicals and Industries Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9.98	12.97	13.98	13.97	16.98	17.98	19.98	21.96	21.96	21.95	21.98	21.94
Reserves	8.99	0.00	−11.99	−31.96	−30.95	−42.96	−61.90	−96.92	−121	−141	−168	−184
Borrowings	60.91	30.98	47.98	55.98	52.94	65.95	111	143	183	194	212	225
Other Liabilities	29.10	73.27	73.28	87.27	103	93.18	91.20	122	91.38	105	103	101
Total Liabilities	108	116	122	126	142	134	159	190	175	178	169	163
Fixed Assets	58.16	93.28	102	101	101	105	118	139	148	150	147	142
CWIP	0.00	10.97	3.99	3.99	2.99	3.99	11.96	7.98	3.99	1.99	2.99	1.99
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	49.82	12.97	15.96	20.93	37.89	23.92	28.92	42.88	23.91	25.92	19.93	19.95
Inventories	5.47	5.66	5.46	11.77	8.99	15.05	16.64	25.62	11.99	9.84	6.05	5.72
Trade receivables	0.36	0.02	1.58	0.31	2.90	0.19	0.29	0.87	0.52	1.89	0.04	0.00
Cash & equivalents	6.32	0.28	0.13	0.43	17.35	0.18	0.72	0.11	0.10	0.15	0.15	0.14
Total Assets	108	116	122	126	142	134	159	190	175	178	169	163

Krebs Biochemicals and Industries cash flow

₹ crore, for each year.

Krebs Biochemicals and Industries Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−44.83	−14.96	−10.96	−5.98	3.99	−35.88	−14.96	−16.96	−24.93	1.99	−7.98	−1.99
Cash from investing activity	−2.99	−3.99	−4.98	−2.99	−3.99	−9.97	−22.92	−22.91	−12.96	−7.97	−4.98	−3.98
Cash from financing activity	54.18	13.05	16.06	9.03	17.05	29.08	38.14	40.14	37.11	6.02	13.05	6.02
Net cash flow	6.01	−6.01	0.00	0.00	17.04	−17.03	1.01	−1.01	0.00	0.00	0.00	0.00
Capex	2.94	0.00	13.29	6.34	5.19	8.69	17.74	27.06	15.15	9.41	3.39	3.18
Free cash flow	−47.96	−22.96	−16.97	−8.98	−0.99	−44.92	−39.93	−40.90	−35.95	−4.99	−10.98	−4.99
CFO / OP %	924.0%	123.1%	140.0%	83.0%	−40.0%	191.0%	83.0%	51.1%	157.0%	−27.0%	52.0%	35.0%

Krebs Biochemicals and Industries ratios

Working-capital days and returns, by year.

Krebs Biochemicals and Industries Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	—	11	181	4	23	3	3	6	5	15	0	0
Inventory days	—	14,703	2,161	336	141	344	233	229	169	542	395	—
Days payable	—	32,251	4,361	511	340	522	293	341	218	1,052	1,193	—
Cash conversion cycle	—	−17,537	−2,019	−171	−176	−175	−58	−107	−45	−495	−796	0
Working capital days	—	−6,531	−2,131	−274	−314	−266	−186	−260	−231	−321	−786	−1,592
ROCE %	−8.0%	−26.0%	−26.0%	−26.0%	−36.0%	−57.0%	−40.0%	−57.0%	−29.0%	−19.0%	−29.9%	−15.0%

Krebs Biochemicals and Industries: frequently asked questions

What are the latest quarterly results of Krebs Biochemicals and Industries?

For the Jun 2026 quarter, Krebs Biochemicals and Industries reported sales of ₹6.97 Cr, up 27.4% year on year and net profit of −₹2.47 Cr. The operating margin was 11.7%.

What is the annual revenue of Krebs Biochemicals and Industries?

Krebs Biochemicals and Industries' sales for the year to Mar 2026 were ₹23.97 Cr; over the last twelve months they were ₹25.19 Cr.

What is the net profit of Krebs Biochemicals and Industries?

Net profit for the year to Mar 2026 was −₹17.02 Cr, and −₹14.11 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−6.58.

How much debt does Krebs Biochemicals and Industries have?

Krebs Biochemicals and Industries reported borrowings of ₹225 Cr at Mar 2026, against cash and equivalents of ₹0.14 Cr.

What is the free cash flow of Krebs Biochemicals and Industries?

Cash from operations was −₹1.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹4.99 Cr.

Loading…